YAVNE, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics ...

Over the years, we’ve heard hundreds of time about how we have enough nuclear weapons to destroy the world. But is that ...

About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...

After the music industry gave out its prestigious Grammys Sunday, the film community is gearing up for its ceremony to take ...

After devastating wildfires tore through Los Angeles, the 97th Academy Awards are going forward. The academy on Wednesday ...

This year’s Doomsday Clock Statement landed like a damp squib in a Trump-swamped corporate news cycle on January 28th. The ...

In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Regeneron (REGN – Research Report), with a price target ...

Patient Capital Management stated the following regarding Coinbase Global, Inc. (NASDAQ:COIN) in its Q4 2024 investor letter: ...

Last year’s Oscar winners Emma Stone, Cillian Murphy, Da’Vine Joy Randolph and Robert Downey Jr. are set to return to the ...

Albemarle (NYSE:ALB – Get Free Report) was downgraded by research analysts at Evercore ISI from an “outperform” rating to an ...

NEW YORK (AP) — NEW YORK (AP) — Oppenheimer Holdings Inc. (OPY) on Friday reported net income of $10.7 million in its fourth quarter. The company, based in New York, said it had earnings of 92 cents ...

Oppenheimer (NYSE:OPY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Monday. Oppenheimer Trading ...